跳到正文
原文
NEJM· @NEJM · X·· 25 天前精选AI 评分75
AI 导读

OCIN 2026 会议上公布的 LATE-MT 试验结果显示,在卒中后 24 至 72 小时仍有可挽救组织的患者中,取栓组 90 天身体功能优于单纯药物治疗,但取栓组脑出血和死亡更常见。完整结果与相关社论已发表于 NEJM 网站。

推荐理由

LATE-MT 试验在 24 至 72 小时时间窗内比较取栓与单纯药物治疗,同时给出疗效与出血、死亡风险的双向结果。

正文

Presented at the OCIN 2026 Conference:

Among patients with salvageable tissue 24 to 72 hours after stroke, physical function at 90 days was better with thrombectomy than with medical care alone, but intracerebral hemorrhage and death were more common with thrombectomy. Full LATE-MT trial results: https://nej.md/3VWTUpV

Editorial: Expanding the Evidence and Indications for Thrombectomy in Ischemic Stroke https://nej.md/4hWsxVs

来源:NEJM · x.com